Several novel tests for the coronavirus disease 2019 (COVID-19) are currently being manufactured, which aim to ameliorate the lag time between testing and results; health expert says that it is currently not possible to conduct contact tracing in Southern states amid the resurgence of COVID-19 cases; survey finds people older than 60 years were no more willing to adhere to social isolation and other preventive measures than younger people.
Reported by The New York Times, several novel tests for the coronavirus disease 2019 (COVID-19) are currently being manufactured, including ones using the gene-editing tool CRISPR, that can spot the virus in less than an hour. Moreover, many of these tests seek to ameliorate the lag time between testing and results, as well as reduce the need for onerous amounts of equipment or trained personnel. As several available point-of-care devices have proven inaccurate, the new tests were noted by researchers to potentially yield more reliable results. However, most of these novel tests are still in their early stages and will not be available in clinics for months.
Amid the resurgence of COVID-19 cases nationwide, especially across Southern states, health expert Peter Hotez, MD, PhD, dean of tropical medicine at Baylor College of Medicine, told CNN that it is currently not possible to conduct contact tracing. So far, cases have risen in at least 31 states, with only 4 states having seen improvements since last week. To address these rising rates, 35 states, along with Washington, DC, and Puerto Rico, now require face coverings in public.
According to survey findings published in PLOS One, people older than 60 years were found to be no more willing to adhere to social isolation and other preventive measures than younger people, despite their increased risk of severe COVID-19 outcomes. Reported by CIDRAP, the survey polled 72,417 adults in 27 countries, including the United States. Although a prior US study indicated that older Americans perceive the pandemic as a significant crisis, survey findings suggest a decreasing compliance to wearing masks for age groups ranging from age 20 to 80 years.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
2 Commerce Drive
Cranbury, NJ 08512